Takeda

takeda.com · Tokyo, Japan

Takeda is a global biopharmaceutical company that researches, develops, manufactures, and commercializes prescription medicines with a focus on oncology, rare genetics and hematology, neuroscience, gastroenterology, and vaccines. It serves patients, healthcare providers, and health systems worldwide through branded drugs and therapies, generating revenue primarily from pharmaceutical product sales and related licensing. The company also engages in R&D partnerships and collaborations with other life sciences organizations.

Revenue
$1B+
Employees
5,001+
Founded
1781
Headquarters
Tokyo, Japan

Takeda customers on Arbolus

Total customers 10 10 current · 0 former
Reviews growth 8 new reviews since Jun 2026

Customers who reviewed Takeda

Seniority of Takeda customers

The largest groups of people who reviewed Takeda hold Director and C-Suite roles (40% each), followed by Manager (20%).

  • Director 40%
  • C-Suite 40%
  • Manager 20%

Customers sample

Revenue Leader Director NPS 7 Will renew
Operations Leader C-Suite NPS 9 Will renew
Legal Leader Manager NPS 9

Employer names and spend open once the report publishes.

What 10 Arbolus experts think of Takeda

Overall sentiment: Positive

NPS scores are highly positive, with five out of eight responses at 9 or 10. Two Influencers and one User in high spend brackets reported NPS of 9–10 and indicated strong or probable renewal intent. Only one User reported a significantly lower NPS (4), with the remaining scores ranging 7–9. All respondents have a relationship longer than one year, and no recent adopters are present. Key themes include sustained satisfaction for high-spend accounts and the occasional outlier in lower engagement roles.

Tell us when the Takeda report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

50 Net Promoter Score, from 10 scored reviews
  • Promoters 6
  • Passives 3
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 60%
  • Will renew 3
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 2 answers
  • Director 50% 2 answers
  • Manager 0% 1 answer
  • 8/10 Average score from customers who will renew
  • 9/10 Average score from undecided customers

Top alternatives

Most weighed by Takeda customers

For people who use Takeda

Do you use Takeda at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 10 customers of Takeda have already contributed

Takes a few minutes. Your identity stays anonymous.